Biomerica 

$1.8750
11
+$0.07+4.17%Thursday 19:59
-$0.07-4%Thursday 20:00After hours

Statistics

Day High
1.82
Day Low
1.82
52W High
3.21
52W Low
1.45
Volume
5
Avg. Volume
-
Mkt Cap
8.62M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Oct 21Expected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.48
-0.15
0.19
0.52
Expected EPS
N/A
Actual EPS
N/A

Financials

-84.77%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.45MRevenue
-3.78MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BMRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
QuidelOrtho
QDEL
Mkt Cap738.56M
Quidel Corporation specializes in diagnostic healthcare products similar to Biomerica's focus, making them direct competitors in the medical diagnostics market.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories offers a broad range of diagnostic tests and devices, competing with Biomerica in multiple healthcare segments including diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap9.87B
Bio-Rad Laboratories, Inc. provides a variety of diagnostic products and systems for the healthcare industry, directly competing with Biomerica's offerings.
Quest Diagnostics
DGX
Mkt Cap25.75B
Quest Diagnostics Incorporated offers diagnostic testing services, making it a competitor by providing similar healthcare diagnostic solutions as Biomerica.
Labcorp
LH
Mkt Cap22.7B
Laboratory Corporation of America Holdings operates in the same clinical laboratory services market as Biomerica, making them competitors in diagnostic testing services.
Thermo Fisher Scientific
TMO
Mkt Cap242.11B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Biomerica in the broader life sciences and diagnostics market.
Becton Dickinson
BDX
Mkt Cap48.16B
Becton, Dickinson and Company offers medical devices and diagnostic products, competing with Biomerica in the healthcare and diagnostics sectors.
Dexcom
DXCM
Mkt Cap32.21B
DexCom, Inc. specializes in glucose monitoring systems, competing with Biomerica in the specific segment of health monitoring and diagnostics.

About

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America generating key revenue from North American Markets.
Show More
CEO
Zackary S. Irani
Employees
50
Country
United States
ISIN
US09061H4065

Listings

0 Comments

Share your thoughts

FAQs

What is Biomerica stock price today?▼
The current price of BMRA is $1.88 USD — it has increased by +4.17% in the past 24 hours. Watch Biomerica stock price performance more closely on the chart.
What is Biomerica stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Biomerica stocks are traded under the ticker BMRA.
Is Biomerica stock price growing?▼
BMRA stock has risen by +2.17% compared to the previous week, the month change is a -20.89% fall, over the last year Biomerica has showed a -37.71% decrease.
What is Biomerica market cap?▼
Today Biomerica has the market capitalization of 8.62M
When is the next Biomerica earnings date?▼
Biomerica is going to release the next earnings report on October 21, 2026.
What is Biomerica revenue for the last year?▼
Biomerica revenue for the last year amounts to 4.45M USD.
What is Biomerica net income for the last year?▼
BMRA net income for the last year is -3.78M USD.
How many employees does Biomerica have?▼
As of October 16, 2026, the company has 50 employees.
In which sector is Biomerica located?▼
Biomerica operates in the Health & Wellness sector.
When did Biomerica complete a stock split?▼
The last stock split for Biomerica was on April 21, 2025 with a ratio of 1:8.
Where is Biomerica headquartered?▼
Biomerica is headquartered in IRVINE, United States.